Patent · US Active

Sustained release small molecule drug formulation

US8852638B2 · kind B2 · utility

37Cited by

5References

20Claims

0Family size

Assignee

Durect Corporation · US

Inventors

Andrew Luk · Castro Valley, US
Gunjan Junnarkar · Palo Alto, US
Guohua Chen · Sunnyvale, US

Key dates

Filing date	Sep 26, 2006
Grant date	Oct 7, 2014
Priority date	—
Expiry date	Jul 22, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.